stock
OFIX · Orthofix Medical Inc.
What Orthofix Medical Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live OFIX price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on OFIX.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 40,732,608 as of 2026-07-31 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- 71.3%
- Operating
- -4.7%
- Net
- -7.4%
Returns
- ROE
- -14.4%
- ROA
- -7.1%
Health
- Current ratio
- 2.8x
- Debt/equity
- 0.5x
Deep value
- NCAV
- $2.29M
- NCAV per share
- $0.06
- Price/NCAV
- Locked
- NNWC
- -$145.93M
- NNWC per share
- -$3.58
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $210.93M | $149.71M | -$8.13M | -$15.80M | 10-Q filed 2026-08-05 |
| 2026-03-31 | $196.71M | $139.55M | -$14.44M | -$20.91M | 10-Q filed 2026-08-05 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | $219.91M | $156.34M | $494,000 | -$2.22M | DEF 14A filed 2026-04-29 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | $205.63M | $148.52M | -$17.05M | -$22.80M | 10-Q filed 2025-11-04 |
| 2025-06-30 | $203.12M | $139.53M | -$16.00M | -$14.08M | 10-Q filed 2026-08-05 |
| 2025-03-31 | $193.65M | $121.62M | -$48.87M | -$53.09M | 10-Q filed 2026-08-05 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | $215.66M | $148.84M | -$11.48M | -$29.15M | DEF 14A filed 2026-04-29 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | $196.61M | $135.05M | -$18.90M | -$27.39M | 10-Q filed 2025-11-04 |
- Assets
- $873.02M
- Equity
- $429.18M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $822.31M | -$81.43M | -$92.19M | — |
| 2024-12-31 | $799.49M | -$84.62M | -$126.00M | — |
| 2023-12-31 | $746.64M | -$139.11M | -$151.40M | -$106.01M |
| 2022-12-31 | $460.71M | -$13.27M | -$19.75M | -$32.90M |
| 2021-12-31 | $464.48M | -$8.31M | -$38.38M | $690,000 |
| 2020-12-31 | $406.56M | -$6.27M | $2.52M | $58.79M |
| 2019-12-31 | $459.95M | -$18.78M | -$28.46M | $13.04M |
| 2018-12-31 | $453.04M | $30.09M | $13.81M | $36.33M |
| 2017-12-31 | $433.82M | $40.81M | $6.22M | $24.31M |
| 2016-12-31 | $409.79M | $21.07M | $3.06M | $42.64M |
Company filings
events
Results, Regulation FD disclosure
ResultsRegulation FD disclosureAug 58-KRegulation FD disclosure
Regulation FD disclosureJul 28-KExecutive or director change, Shareholder vote results
Executive or director changeShareholder vote resultsJun 118-KRegulation FD disclosure
Regulation FD disclosureMay 218-KResults, Regulation FD disclosure
ResultsRegulation FD disclosureMay 58-KResults, Executive or director change
ResultsExecutive or director changeApr 98-K
5% owners ()
Armistice Capital, LLC
Stake update
Juniper Targeted Opportunity Fund, L.P.
Stake update
Armistice Capital, LLC
Stake update
The Vanguard Group
Stake update
Armistice Capital, LLC
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
Fisher Patrick
President, Global Limb Recon
Sale$1,416Oct 5, 4:20 PM ET
Juniper Investment Company, LLC
10% owner
Buy$2,732,097Sep 23, 3:52 PM ET
Juniper Investment Company, LLC
10% owner
Sale$2,732,097Sep 22, 4:26 PM ET
Fisher Patrick
President, Global Limb Recon
Sale$1,409Sep 3, 4:41 PM ET
Fisher Patrick
President, Global Limb Recon
Sale$13,067Aug 20, 5:03 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
News
Stories that named OFIX, and the market events around them.
Sign in to see thisBoard
Recent signals
Signals open up here once a member has posted about OFIX.
Signals are informational.
Posts · 0
No posts yet.
nakagai
Signals on OFIX come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the OFIX board